U.S. health insurers look bad, Fitch warns

By Allison Bell

News January 02, 2026 at 02:56 PM

Share & Print

What You Need To Know

Fitch is assuming employer plan medical costs will rise by about 9% this year.
The cost of GLP-1 agonist weight-loss drugs is enough of a concern to show up on the list of threats.
Another concern is complex, high-cost claims.

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.